Category: Pharmacotherapy and Experimental Therapeutics
Nithya Srinivas receives ASCPT Presidential Trainee Award
January 7, 2016Nithya Srinivas, a Ph.D. student in the Division of Pharmacotherapy and Experimental Therapeutics at the UNC Eshelman School of Pharmacy, has been awarded a 2016 Presidential Trainee Award through the American Society of Clinical Pharmacology Therapeutics. The award recognizes her abstract, “Antiretroviral Drug Exposure in Cerebrospinal Fluid (CSF) as a Predictor of Neurocognitive Outcomes in HIV Infected Patients,” and indicates it received a top score when compared to other project submitted by clinical pharmacologists in training. Srinivas graduated with her Bachelor of Science in pharmacy in 2014 in Bangalore, India, and is completing her Ph.D. under the guidance of Angela … Read more
Rhoney, Rodgers Receive ACCP Practice and Research Networks Awards
October 12, 2015Two faculty members from the UNC Eshelman School of Pharmacy have been selected for Practice and Research Networks awards from the American College of Clinical Pharmacy. Denise Rhoney, Pharm.D., has been chosen as the 2015 recipient of the Critical Care PRN Education Award. According to the recognition committee, the award recognizes individuals who have demonstrated excellence in the classroom or clinical training site, conducted innovative research, demonstrated dedication to clinical pharmacist continuing professional development and shown leadership in the development of clinical pharmacy education programs. “There are few individuals who have contributed more to critical care clinical pharmacy. We can … Read more
PK/PD Modeling Expert Alan Forrest Joins DPET Faculty
October 6, 2015Alan Forrest, Pharm.D., a researcher and educator with more than 30 years’ experience in pharmacokinetic and pharmacodynamics modeling, has joined the UNC Eshelman School of Pharmacy as a clinical professor in the Division of Pharmacotherapy and Experimental Therapeutics. “Dr. Forrest is internationally recognized as a leader in the field of pharmacometrics whose innovative research in optimizing individual patient therapy and in advanced application of pharmacokinetic, pharmacodynamic and toxicodynamic systems analysis has impacted drug development and pharmacotherapy in meaningful ways,” says Dean Bob Blouin, Pharm.D. “He is recognized widely as the expert on adaptive feedback control and individualizing therapy using novel … Read more
Amber Proctor Joins School in First DPET Position Shared with UNC Hospitals
August 24, 2015Amber Proctor, Pharm.D., has joined the UNC Eshelman School of Pharmacy as one of the newest members of the Division of Pharmacotherapy and Experimental Therapy. Proctor’s appointment is cofunded by UNC Hospitals, where she will also act as a clinical oncology specialist in thoracic oncology. Proctor began her appointment on August 1, 2015, after completing a PGY2 hematology and oncology pharmacy specialty residency at UNC Hospitals in June. “I am thrilled that Amber Proctor is DPET’s first shared position with the UNC Medical Center,” said Angela Kashuba, Pharm.D., DPET chair and John and Deborah McNeill Jr. Distinguished Professor. “She will … Read more
Yanguang Cao Joins DPET Faculty as Assistant Professor
August 24, 2015Yanguang “Carter” Cao, Ph.D., has joined the Division of Pharmacotherapy and Experimental Therapeutics at the UNC Eshelman School of Pharmacy as of August 1. Cao comes to UNC from the State University of New York at Buffalo. “Dr. Cao’s dedication to research, his ability to be an effective teacher and his many outstanding personal attributes bode well for success here at the School,” says Angela Kashuba, Pharm.D., DPET chair and the John and Deborah McNeill Jr. Distinguished Professor. “He is a promising young investigator in the quantitative sciences, and he will be a highly valuable addition to our faculty at … Read more
Daniel Crona to Join DPET as Assistant Professor
August 18, 2015Daniel Crona, Pharm.D., Ph.D., will join the Division of Pharmacotherapy and Experimental Therapeutics at the UNC Eshelman School of Pharmacy as a tenure-track assistant professor on October 1. Crona will also have an appointment at the North Carolina Cancer Hospital where he will work as a clinical pharmacist specialist in genitourinary oncology. Crona’s research has focused on identifying and validating novel genetic variants associated with survival in patients with advanced or metastatic kidney cancer. Discovery of these variants could help health-care providers identify the patients that would benefit most from different oral chemotherapeutics. “Dan Crona is a highly promising young … Read more
School Wins TBJ Life Sciences Award for Chemo-Cleaning Wipe
May 22, 2015The UNC Eshelman School of Pharmacy received a 2015 BDO Life Sciences Award from the Triangle Business Journal on May 21 in the category of outstanding research university. The School won for the work of William Zamboni, PharmD, PhD, and Stephen Eckel, PharmD, MHA, in developing wipe kits that detect and remove hazardous residue left on surfaces from the preparation of chemotherapy drugs. Eckel, a leading expert on the issue of chemotherapy contamination in the workplace, says studies have found that people who prepare and administer chemotherapy drugs are at risk of developing complications from exposure to those drugs. Despite … Read more
Kashuba to Chair Pharmacotherapy and Experimental Therapeutics
May 14, 2015Internationally known AIDS and HIV researcher Angela Kashuba, PharmD, has been appointed chair of the Division of Pharmacotherapy and Experimental Therapeutics at the UNC Eshelman School of Pharmacy. Kashuba succeeds Kim Brouwer, PharmD, PhD, who has been named associate dean of research and graduate education at the School. Kashuba, is the School’s John A. and Deborah S. McNeill Jr. Distinguished Professor and studies the role of antiretroviral therapy in preventing the transmission of HIV along with the optimal dosing and drug combinations for treating HIV infection. She works to better understand and predict the distribution of drugs throughout the body, … Read more
Brouwer Appointed Associate Dean for Research and Graduate Education
May 14, 2015Kenan Professor Kim L. R. Brouwer, PharmD, PhD, has been named associate dean of research and graduate education at the UNC Eshelman School of Pharmacy. Angela Kashuba, PharmD, the John A. and Deborah S. McNeill Jr. Distinguished Professor, will succeed Brouwer as chair of the Division of Pharmacotherapy and Experimental Therapeutics. Brouwer is the William R. Kenan Jr. Distinguished Professor in DPET and a professor in the curriculum in toxicology in the School of Medicine. She served as the DPET chair from 2004 until her appointment as associate dean. She previously served as the School’s director of graduate studies from … Read more
Kashuba to Play Role in New UNC-GSK Partnership to Accelerate Search for HIV Cure
May 11, 2015The University of North Carolina at Chapel Hill, a leading global public research university with significant expertise in HIV basic and clinical research, and GSK, a global, research-based pharmaceutical and health-care company with a legacy of success in developing treatments for HIV, today announced the creation of the dedicated HIV Cure center and a jointly owned new company that will focus on discovering a cure for HIV/AIDS. This unique public-private partnership will redefine the traditional way of conducting research and create a new model to seek the breakthroughs needed to tackle an extraordinarily challenging global health issue. The HIV Cure … Read more